Literature DB >> 10199938

Uptake of positron emission tomography tracers in experimental bacterial infections: a comparative biodistribution study of radiolabeled FDG, thymidine, L-methionine, 67Ga-citrate, and 125I-HSA.

Y Sugawara1, T D Gutowski, S J Fisher, R S Brown, R L Wahl.   

Abstract

The purpose of this study was to evaluate the localization of positron emission tomography (PET) tracers [2-deoxy-2-fluoro-D-glucose (FDG), thymidine, and L-methionine] in sites of bacterial infection, and to contrast this with that of other tracers. The left calf muscles of rats were infected with a suspension of Escherichia coli and the biodistribution of 18F- or 3H-FDG, 3H-thymidine, L-11C- or 3H-methionine, gallium-67 citrate (67Ga-citrate) and iodine-125 human serum albumin (125I-HSA) was determined in these animals. 3H-FDG uptake in the infectious foci was evaluated by autoradiography of histological sections. Although 18F-FDG, 67Ga-citrate, and 125I-HSA showed comparatively high uptake in the infected muscle [the percentage activity of injected dose (ID) per gram of tissue normalized for rat weight in kilogram (%ID/g)xkg at 2 h postinjection was as follows: 18F-FDG, 0.184+/-0.026 to 0.218+/-0.046; 67Ga-citrate, 0.221+/-0.016; 125I-HSA, 0. 198+/-0.019], the infected muscle to blood ratio was much higher for 18F-FDG than for 67Ga-citrate or 125I-HSA (18F-FDG, 10.31+/-0.76 to 14.89+/-2.26; 67Ga-citrate, 1.24+/-0.67; 125I-HSA, 0.20+/-0.02). The draining reactive lymph nodes also showed higher accumulation of 18F-FDG than of 67Ga-citrate or 125I-HSA. The uptake of 3H-thymidine and L-11C- or 3H-methionine in the infected muscle was lower than that of 18F- or 3H-FDG (at 2 h postinjection, 3H-thymidine = 0. 039+/-0.005 and L-3H-methionine = 0.063+/-0.007 (%ID/g)xkg. Autoradiographs showed that the highest 3H-FDG uptake was seen in the area of inflammatory cell infiltration surrounding the necrotic region. In conclusion, 18F-FDG, which rapidly accumulates in sites of bacterial infection and in reactive lymph nodes with a high target to background ratio, appears to be a promising infection detection agent.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10199938     DOI: 10.1007/s002590050395

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  22 in total

1.  Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation.

Authors:  Chantal P Bleeker-Rovers; Elisabeth M H A de Kleijn; Frans H M Corstens; Jos W M van der Meer; Wim J G Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-10       Impact factor: 9.236

2.  Comparison of autologous (111)In-leukocytes, (18)F-FDG, (11)C-methionine, (11)C-PK11195 and (68)Ga-citrate for diagnostic nuclear imaging in a juvenile porcine haematogenous staphylococcus aureus osteomyelitis model.

Authors:  Ole L Nielsen; Pia Afzelius; Dirk Bender; Henrik C Schønheyder; Páll S Leifsson; Karin M Nielsen; Jytte O Larsen; Svend B Jensen; Aage Ko Alstrup
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-01-15

3.  Comparison of 18F-FDG and 68Ga PET imaging in the assessment of experimental osteomyelitis due to Staphylococcus aureus.

Authors:  Tatu J Mäkinen; Petteri Lankinen; Tiina Pöyhönen; Jari Jalava; Hannu T Aro; Anne Roivainen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07-09       Impact factor: 9.236

4.  Efficacy of ciprofloxacin-releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus.

Authors:  Jyri K Koort; Tatu J Mäkinen; Esa Suokas; Minna Veiranto; Jari Jalava; Juhani Knuuti; Pertti Törmälä; Hannu T Aro
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

5.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Authors:  Abass Alavi; Søren Hess; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

Review 6.  Biomaterials approaches to treating implant-associated osteomyelitis.

Authors:  Jason A Inzana; Edward M Schwarz; Stephen L Kates; Hani A Awad
Journal:  Biomaterials       Date:  2015-12-18       Impact factor: 12.479

7.  Nuclear medicine imaging of infection in cancer patients (with emphasis on FDG-PET).

Authors:  Chantal P Bleeker-Rovers; Fidel J Vos; Winette T A van der Graaf; Wim J G Oyen
Journal:  Oncologist       Date:  2011-06-16

8.  [Diagnosis of chronic osteitis of the bones in the extremities. Relative value of F-18 FDG-PET].

Authors:  M Goebel; F Rosa; K Tatsch; A Grillhoesl; G O Hofmann; M H Kirschner
Journal:  Unfallchirurg       Date:  2007-10       Impact factor: 1.000

Review 9.  Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Authors:  Daniel J Scherer; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

10.  Intrapatient comparison of 2-deoxy-2-[F-18]fluoro-D-glucose with positron emissiontomography/computed tomography to Tc-99m fanolesomab (NeutroSpec) for localization of infection.

Authors:  William C Klingensmith; Daniel Perlman; Kenneth Baum
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.